Methamphetamine (METH) is a highly addictive and neurotoxic psychostimulant. Its use in
humans is often associated with neurocognitive impairment. Whether this is due to long …

Although it has been initially synthesized for therapeutic purposes and currently FDA-
approved and prescribed for obesity, attention-deficit/hyperactivity disorder, narcolepsy and …

The presynaptic source of dopamine in the CA1 field of dorsal hippocampus is uncertain
due to an anatomical mismatch between dopaminergic terminals and receptors. We show, in …

The brain reward circuitry plays a key role in emotional and motivational behaviors, and its
dysfunction underlies neuropsychiatric disorders such as schizophrenia, depression and …

Methamphetamine affects the hippocampus, a brain region crucial for learning and memory,
as well as relapse to drug seeking. Rats self-administered methamphetamine for 1 h twice …

Oxytocin (OT), a neurohypophyseal neuropeptide, affects adaptive processes of the central
nervous system. In the present study, we investigated the effects of OT on extracellular levels …

Although evidence suggests that DA modulates hippocampal function, the mechanisms
underlying that dopaminergic modulation are largely unknown. Using perforated-patch …

Methamphetamine (METH) is an addictive psychostimulant whose societal impact is on the
rise. Emerging evidence suggests that psychostimulants alter synaptic plasticity in the brain …

Amphetamines have rewarding and aversive effects. Relative sensitivity to these effects may
be a better predictor of vulnerability to addiction than sensitivity to one of these effects alone …

Exposure to drugs of abuse induces plasticity in the brain and creates persistent drug‐
related memories. These changes in plasticity and persistent drug memories are believed to …